| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 11/08/2001 | CA2407746A1 Proteases |
| 11/08/2001 | CA2407737A1 Regulatory nucleic acid for the abc1 gene, molecules modifying its activity and therapeutic uses |
| 11/08/2001 | CA2407713A1 A core formulation |
| 11/08/2001 | CA2407597A1 Tricyclic fused pyridine and pyrimidine derivatives as crf receptor antagonists |
| 11/08/2001 | CA2407587A1 Ppar.gamma. modulators |
| 11/08/2001 | CA2407435A1 Rna metabolism proteins |
| 11/08/2001 | CA2407337A1 A medicinal aerosol formulation |
| 11/08/2001 | CA2407189A1 New gamma selective retinoids |
| 11/08/2001 | CA2407129A1 Medicinal formulation comprising pioglitazone |
| 11/08/2001 | CA2406999A1 Gene and sequence variation associated with sensing carbohydrate compounds and other sweeteners |
| 11/08/2001 | CA2405832A1 P-(sulfonyl)aryl and heteroaryls |
| 11/08/2001 | CA2405611A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoindane derivatives |
| 11/08/2001 | CA2378001A1 Preparation for nasal absorption of insulin |
| 11/07/2001 | EP1152055A1 ADAMTS polypeptides, nucleic acids encoding them, and uses therof |
| 11/07/2001 | EP1152002A1 Pyrrole derivatives and cell death inhibitors |
| 11/07/2001 | EP1151998A1 Estrogen agonists/antagonists |
| 11/07/2001 | EP1151995A1 Process for the preparation of the mesylate salt trihydrate of 1-(4-Hydroxyphenyl)-2-(4-Hydroxy-4-Phenylpiperidin-1-YL)-1-Propanol |
| 11/07/2001 | EP1151993A1 Cyclic amine derivatives and uses thereof |
| 11/07/2001 | EP1151756A1 Application of polyacrylamide gel for forming a capsule in the tissue of a mammal organism, method for cultivating cells and method for therapy of oncological diseases and the diabetes mellitus |
| 11/07/2001 | EP1151752A2 Method for inhibiting bone resorption |
| 11/07/2001 | EP1151113A2 Human peptidases |
| 11/07/2001 | EP1151102A1 Glycosylated leptin compositions and related methods |
| 11/07/2001 | EP1151101A1 Prostacyclin-stimulating factor-2 |
| 11/07/2001 | EP1151067A1 Process of converting rendered triglyceride oil from marine sources into bland, stable oil |
| 11/07/2001 | EP1150997A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 11/07/2001 | EP1150982A1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND I$g(k)-A$g(a) |
| 11/07/2001 | EP1150977A1 Phenyl urea and phenyl thiourea derivatives as orexin receptor antagonists |
| 11/07/2001 | EP1150963A1 Substituted 4-amino-2-aryltetrahydroquinazolines, their preparation, their use and pharmaceutical compositions comprising them |
| 11/07/2001 | EP1150961A1 Pyrazolecarboxylic acid derivatives, their preparation, pharmaceutical compositions containing them |
| 11/07/2001 | EP1150960A1 Polymorphic crystalline forms of celecoxib |
| 11/07/2001 | EP1150959A1 Solid-state form of celecoxib having enhanced bioavailability |
| 11/07/2001 | EP1150950A2 Anthranilic acid derivatives |
| 11/07/2001 | EP1150715A1 Pharmaceutical compositions containing nicotine or a ligand of nicotine receptors and a monamine oxydase inhibitor and their use for treating tobacco withdrawal symptoms |
| 11/07/2001 | EP1150679A1 Use of cholesterol-lowering agent |
| 11/07/2001 | EP1150678A1 Use of 3-hydroxy-3-methylglutaryl coenzym a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy |
| 11/07/2001 | EP1150674A1 Use of pyrrolidine derivatives for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of obesity or appetite regulation |
| 11/07/2001 | EP1150669A1 L-arginine based formulations for treating diseases and methods of using same |
| 11/07/2001 | EP1150658A2 Method for controlling liposome size |
| 11/07/2001 | EP1150579A1 Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven-carbon fatty acid |
| 11/07/2001 | EP1150574A1 A natural tea for curing men's impotence and a method for manufacturing the same |
| 11/07/2001 | EP1003532B1 Lactobacilli to increase absorption of minerals by intestinal cells |
| 11/07/2001 | EP0925273B1 Pharmaceutical composition containing 4-oxo-butynic acids |
| 11/07/2001 | EP0879223B1 Aromatic polycyclic retinoid-type derivatives, method for preparing same, and use thereof for making pharmaceutical and cosmetic compositions |
| 11/07/2001 | EP0871626B1 triazolones as apolipoprotein-b synthesis inhibitors |
| 11/07/2001 | EP0848705B1 Crystalline r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4- (phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) |
| 11/07/2001 | EP0769917B1 Nervonic acid compositions |
| 11/07/2001 | EP0758452B1 Modulators of cytokines of the tgf-beta superfamily and methods for assaying for same |
| 11/07/2001 | EP0546108B1 Pro-drugs for cck antagonists |
| 11/07/2001 | CN1321166A Propanolamine derivs. linked with bile acid used for treating disorders of lipid metabolism |
| 11/07/2001 | CN1321158A Tricyclic delta 3-piperidines as pharmaceuticals |
| 11/07/2001 | CN1321154A Propanolamine derivs. substd. with heteocyclic compound, methods for their production, pharmaceutical compositions contg. said compounds and use thereof |
| 11/07/2001 | CN1321152A Substd. oxazoles and thiazoles derivs. as hPPAR gamma and hPPAR alpha activators |
| 11/07/2001 | CN1321150A Amide derivs. useful as inhibitors of production of cytokines |
| 11/07/2001 | CN1321148A Aryl-substd. propanolamine derivs., method for their production, medicaments contg. said compounds and their use |
| 11/07/2001 | CN1320599A Limited 9-cis-isotretinoins |
| 11/07/2001 | CN1320456A Chinese-medicinal capsule for treating diabetes and its preparing process |
| 11/07/2001 | CN1320448A Cr-contained balsam pear buccal lozenge and its preparing process |
| 11/07/2001 | CN1320438A Process for preparing medicines |
| 11/07/2001 | CN1320428A Instant effervescent particles for Ca-supplementing health-care products and its preparing process |
| 11/07/2001 | CN1320423A Medicine composition and method for suppressing inter-racemization of L-amino acids |
| 11/06/2001 | US6313298 Spiro-indolines as Y5 receptor antagonists |
| 11/06/2001 | US6313290 Azolobenzazepine derivatives and compositions and method of use thereof |
| 11/06/2001 | US6313175 For therapy of obesity; for quantitating the binding of serotonin or a serotonin ligand |
| 11/06/2001 | US6313171 Method for preventing or treating elevated blood lipid level-related diseases by administering cinnamic acid derivatives |
| 11/06/2001 | US6313162 Propynyl or dienyl biaromatic compounds |
| 11/06/2001 | US6313160 Substituted heterocyclic compounds, method for preparing and compositions containing same |
| 11/06/2001 | US6313146 Calcium receptor-active molecules |
| 11/06/2001 | US6313142 Method for making 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline |
| 11/06/2001 | US6313129 Therapeutic compounds |
| 11/06/2001 | US6313127 For therapy of hypercholesterolemia or atherosclerosis |
| 11/06/2001 | US6313118 Hydroxytryptamine receptor antagonists |
| 11/06/2001 | US6313117 Succinate derivative compounds useful as cysteine protease inhibitors |
| 11/06/2001 | US6313116 Phosphodiesterase inhibitors |
| 11/06/2001 | US6313107 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI |
| 11/06/2001 | US6312898 Diagnosing and treating subjects having increased risk for the development of the disease using polymerase chain reaction and/or sequencing methods to determine amino acid polymorphism in the protein |
| 11/06/2001 | US6312753 Cocoa components, edible products having enriched polyphenol content, methods of making same and medical uses |
| 11/06/2001 | US6312703 Drugs or cosmetics, liquid crystal solids and lecithin |
| 11/06/2001 | US6312665 Aerosol formulations for buccal and pulmonary application |
| 11/06/2001 | US6312663 Prediction of diabetes impaired wound healing by urinary nitrate assay |
| 11/03/2001 | CA2345760A1 Pharmaceutical uses for fluoroalkoxybenzylamino and alkoxybenzylamino derivatives of nitrogen containing heterocycles |
| 11/01/2001 | WO2001081590A2 Protein phosphatases |
| 11/01/2001 | WO2001081585A2 A thymus expressed human cytochrome p450 (p450tec) |
| 11/01/2001 | WO2001081562A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof |
| 11/01/2001 | WO2001081415A2 Parathyroid hormone and parathyroid hormone-related protein antagonists |
| 11/01/2001 | WO2001081408A2 G-protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same |
| 11/01/2001 | WO2001081376A2 Apo-ai/aii peptide derivatives |
| 11/01/2001 | WO2001081348A1 USE OF 5-THIO-, SULFINYL- AND SULFONYLPYRAZOLO[3,4-b]-PYRIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS |
| 11/01/2001 | WO2001081346A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 11/01/2001 | WO2001081344A1 Salts of bicyclic, n-acylated imidazo-3-amines and imidazo-5-amines |
| 11/01/2001 | WO2001081337A1 Inhibitors of dipeptidyl peptidase iv |
| 11/01/2001 | WO2001081328A2 Thiazolidinedione analogues and their use for the treatment of diabetes |
| 11/01/2001 | WO2001081323A1 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments |
| 11/01/2001 | WO2001081311A1 Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis |
| 11/01/2001 | WO2001081310A1 1-aroyl-piperidinyl benzamidines |
| 11/01/2001 | WO2001081304A1 Inhibitors of dipeptidyl peptidase iv |
| 11/01/2001 | WO2001081298A2 Cyclic carboxylic acids as integrin antagonists |
| 11/01/2001 | WO2001081295A1 Cyclohexylamine derivative as subtype selective nmda receptor antagonists |
| 11/01/2001 | WO2001080989A1 Transparent liquid composition |
| 11/01/2001 | WO2001080853A1 A combination of pinitol and creatine to enhance uptake and retention of creatine |
| 11/01/2001 | WO2001080852A1 Compositions and therapies for hyperlipidaemia-associated disorders |